The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, January 18, 2022, According to the requirements of art. 100t of LPOS, „Sopharma“ AD (the Company) notifies that it starts the payment of amounts from the sale of unexercised rights with ISIN BG4000006214 at a service auction held on the “Bulgarian Stock Exchange” AD on December 6, 2021.
Sofia, Bulgaria, January 10, 2022 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for December 2021 the Company recorded a decrease in sales of 4% compared to the same month of the previous year, incl. 32% decrease in domestic sales and 19% increase in export sales.
Sofia, Bulgaria, January 6, 2022 – According to the requirements of Art. 100t of LPOS and in connection with Art. 114, para. 9 of the Law on Public Offering of Securities, “Sopharma” AD announces that today, according to a decision of the Board of Directors dated December 21, 2021, the company concluded the following transactions falling within the scope of Art. 114, para. 2 of the LPOS:
1. “Sopharma” AD as a BUYER concluded a Contract for purchase and sale of 13 (thirteen) motor vehicles, owned by “Telecomplect” AD, UIC 831643753.
Sofia, Bulgaria, December 30, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that the subscription for the public offering of the warrants of the Company has been successfully completed.
The results of the public offering are as follows: